Synopsis of recent research by authors named "Shaoyi Sun"
- Recent research by Shaoyi Sun focuses on the development of novel, selective sodium channel inhibitors, particularly targeting Na1.6 and Na1.7, to enhance the efficacy of antiseizure medications and pain management therapies.
- His studies have identified new chemical entities, such as NBI-921352 and various acyl sulfonamides, demonstrating potential in treating epilepsy and pain with reduced side effects compared to existing therapies.
- Additionally, Sun's work highlights the significance of biologically active metabolites and methylation in drug design, providing insights into optimizing pharmacokinetic properties and designing safer, more effective therapeutics.*